(Q36115655)

English

Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

author name string

Saunders MI

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Rojas A

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Lyn BE

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Pigott K

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Powell M

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Goodchild K

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hoskin PJ

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Phillips H

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Verma N

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

1 November 1998

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

78

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1323-1328

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1998.678

0 references

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063173

2 October 2017

Therapeutic options for regionally advanced non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063173

2 October 2017

A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063173

2 October 2017

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063173

2 July 2018

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063173

2 July 2018

Assessment of Human Tumour Proliferation Using Bromodeoxyuridine—Current Status

1 reference

https://pubmed.ncbi.nlm.nih.gov/9823973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9823973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/9823973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9823973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The recording of morbidity related to radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9823973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled clinical trial of misonidazole in the radiotherapy of patients with carcinoma of the bronchus

1 reference

https://pubmed.ncbi.nlm.nih.gov/9823973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary tumor control after radiotherapy for carcinoma of the bronchus

1 reference

https://pubmed.ncbi.nlm.nih.gov/9823973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9823973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1998.678

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36115655&oldid=1966814971"